Post-marketing Pharmacovigilance and Medical Information Market Report 2022 And Industry Forecast Till 2027
IMARC Group has recently released a new research study βPost-marketing Pharmacovigilance and Medical Information Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027β, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of Post-marketing Pharmacovigilance and Medical Information Market?
The global post-marketing pharmacovigilance and medical information market size reached US$ US$ 4.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 8.82 Billion on by 2027, exhibiting a growth rate (CAGR) of 11.20% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request For Sample Report:
https://www.imarcgroup.com/post-marketing-pharmacovigilance-medical-information-market/requestsample
What is a the Post-marketing Pharmacovigilance and Medical Information Market ?
Post-marketing pharmacovigilance and medical information refer to the practices of monitoring the efficacy and safety of medical devices and drugs after their launch.
They can be categorized into spontaneous reporting, targeted spontaneous reporting, cohort event monitoring, intensified adverse drug reaction (ADR) reporting, etc., and include collection, surveillance, and prevention of the adverse effects of new medicines and equipment. Post-marketing pharmacovigilance and medical information methods help protect patients from unnecessary harm by clarifying risks and refuting false indications.
They assist researchers in determining required actions throughout the drug formulation cycle. Consequently, post-marketing pharmacovigilance and medical information services find extensive applications in hospitals and research organizations across the globe.
What are the major market drivers in a Post-marketing Pharmacovigilance and Medical Information Market ?
The growing geriatric population and the increasing occurrence of diabetes, dementia, hypertension, cardiovascular diseases, and osteoporosis are among the key factors driving the post-marketing pharmacovigilance and medical information market. In
addition to this, the escalating prevalence of adverse drug reactions (ADRs) is acting as another significant growth-inducing factor. Furthermore, the expanding hospitals, clinics, medical research centers, and laboratories, especially in developing countries, is also positively influencing the global market.
Apart from this, the introduction of several initiatives and policies by the government bodies aimed at improving the healthcare infrastructure and pharmacovigilance services and maintaining medical databases is further catalyzing the market growth.
Moreover, the elevating focus among leading market players on outsourcing pharmacovigilance operations (PVO) and the development of cloud-based medical information systems that offer optimal accuracy, cost-effectiveness, efficient risk mitigation, improved timelines, and enhanced organizational agility are anticipated to propel the post-marketing pharmacovigilance and medical information market over the forecasted period.
| Post-marketing Pharmacovigilance and Medical Information Market Report Scope | |
| Report Coverage | Details |
| Market size value in 2021 | US$ US$ 4.56 Billion |
| Market forecast in 2027 | US$ 8.82 Billion |
| Growth Rate | CAGR of 11.20%from 2022 to 2027 |
| Base year for estimation | 2021 |
| Historical data | 2016-2021 |
| Forecast period | 2022-2027 |
| Report coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments covered | Type, Product And End User |
| Regional scope | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Key companies profiled | Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd. |
| Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Click here to view detailed information with table of content: https://www.imarcgroup.com/post-marketing-pharmacovigilance-medical-information-market
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Type:
Spontaneous Reporting Intensified ADR Reporting Targeted Spontaneous Reporting Cohort Event Monitoring EHR Mining
Breakup by Product: Books Online Media Journals
Breakup by End User: Hospitals Research Organization Breakup by End User: Hospitals Research Organization By Geography:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
The major players in the market are Accenture Plc. ArisGlobal, Cognizant Technology Solutions Corporation Ergomed Plc, F. Hoffmann-La Roche Ltd. Icon Plc, Parexel International Corporation Pharmaceutical Product Development Inc. and Wipro Ltd.
πππ² π‘π’π π‘π₯π’π π‘ππ¬ π¨π ππ‘π π«ππ©π¨π«π:
β’ Market Performance (2016-2021)
β’ Market Outlook (2022- 2027)
β’ Porter's Five Forces Analysis
β’ Market Drivers and Success Factors
β’ SWOT Analysis
β’ Value Chain
β’ Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCβs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companyβs expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA β Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
